Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Zhonghua Liu Xing Bing Xue Za Zhi ; 42(2): 335-342, 2021 Feb 10.
Article in Chinese | MEDLINE | ID: mdl-33626625

ABSTRACT

Objective: Mycoplasma genitalium (Mg) is an opportunity pathogenic microorganism mainly transmitted through sexual contact. In recent years, scholars have paid more attention to Mg infection and pathogenicity. This study was aimed to understand the condition of Mg in the genitourinary tract of different populations in China and provide evidence for further study of its pathogenic characteristics. Methods: Cross-section studies of Mg infection in the Chinese community were searched by China National Knowledge Infrastructure (CNKI), Wanfang digital database, SinoMed, Pubmed, and Web of Science from database construction to March 10th, 2020. Studies were sifted and screened independently by two evaluators based on inclusion and exclusion criteria, and Meta-analysis was conducted with R 1.1.463. If I2≤50%, the fixed-effect model should be adopted, if I2>50%, the random effect model should be adopted, and through subgroup analysis, the source of heterogeneity should be found out as far as possible. Results: A total of 47 research articles were included in this article, all of which were medium and high-quality articles. There was no obvious publication bias, and the results were more reliable. The research contained 19 provinces and Hong Kong Special administrative region, including 519 healthy people, 10 504 patients from clinics or hospitals of sexual transmitted disease (STD), 3 200 on Gynecology and 1 624 on Urology, 1 082 patients with men who have sex with men(MSM), 1 842 patients with Female sex worker(FSW), and 3 691 patients with HIV/AIDS. The infection rate of Mg in the genitourinary tract of the healthy population was 0.94% (95%CI: 0.07%-2.78%), the infection rate of Mg was 11.58% (95%CI: 8.57%-14.97%), 15.22% (95%CI: 7.99%-24.27%), 7.32% (95%CI: 4.24%-11.16%) among patients from clinics or hospitals of STD, gynecology and urology respectively. The infection rate of MSM was 9.70% (95%CI: 3.06%-19.52%),the infection rate of FSW was 13.49% (95%CI: 11.97%-15.08%). The infection rate of Mg among HIV infected patients was 20.46% (95%CI: 13.67%-28.22%). Conclusions: The infection rate of Mg in a healthy population was low. Mg infection rate in the genitourinary tract of other groups was still higher, which is worthy of further attention.


Subject(s)
Mycoplasma Infections , Mycoplasma genitalium , Population Groups , China/epidemiology , Cross-Sectional Studies , Humans , Mycoplasma Infections/epidemiology , Population Groups/statistics & numerical data
2.
Zhonghua Yi Xue Za Zhi ; 100(45): 3584-3589, 2020 Dec 08.
Article in Chinese | MEDLINE | ID: mdl-33333681

ABSTRACT

Objective: To analyze the incidence of heterotopic ossification after artificial cervical disc replacement with Discover disc, and to explore the effect of heterotopic ossification on postoperative radiological and clinical efficacy. Methods: From January 2010 to January 2015, 45 patients with cervical spondylosis underwent single-level artificial cervical disc replacement in Shanghai Changzheng Hospital, including 29 cases of cervical spondylotic myelopathy, 11 cases of cervical spondylotic radiculopathy and 5 cases of mixed cervical spondylosis. At the last follow-up, Mehren grading method was used for classification of heterotopic ossification, among which, grade 0-Ⅱ was defined as low grade ossification group, and 26 patients (16 male, 10 female) were enrolled in this group; grade Ⅲ-Ⅳ was defined as high grade ossification group, and 19 patients (12 males, 7 females) were included in this group. C(2-7) Cobb angle, cervical total range of motion and range of motion at index level were used to evaluate the radiological outcomes of the two groups. Japanese Orthopaedic Association (JOA) score, neck disability index (NDI) score and visual analogue scale (VAS) were used to evaluate the clinical outcomes of the two groups. The adjacent segment intervertebral disc height and range of motion were used to evaluate the effects of heterotopic ossification on adjacent segment. Results: All patients were followed up regularly for (98±18) months. There were no statistical differences between the two groups regarding to demographic data (all P>0.05). There was no significant differences in C(2-7) Cobb angle and total range of motion between the two groups at the last follow-up (all P>0.05), but range of motion at index level in the group with low grades was significantly higher than that in the group with high grades (7.8°±6.2° vs 2.6°±1.2°, t=3.60, P<0.05). There was no significant differences in JOA score, recovery rate and NDI score between the two groups (all P>0.05). There was no significant differences in the adjacent segment intervertebral disc height before operation and at the last follow-up (both P>0.05). There was no significant differences in range of motion at adjacent segment before operation (P>0.05), while range of motion at adjacent segment in the group with low grades was significantly lower than that in the group with high grades (9.5°±1.1° vs 10.6°±1.8° and 9.4°±1.4° vs 10.5°±1.7°, repectively, t=2.54, 2.31, both P<0.05). Conclusions: Heterotopic ossification does not affect the clinical outcomes, cervical curvature and cervical total range of motion after artificial cervical disc replacement with Discover disc. However, the higher grade of heterotopic ossification, the lower range of motion at index level and the higher range of motion at adjacent segment.


Subject(s)
Intervertebral Disc Degeneration , Intervertebral Disc , Ossification, Heterotopic , Total Disc Replacement , Cervical Vertebrae/surgery , China , Female , Follow-Up Studies , Humans , Intervertebral Disc Degeneration/surgery , Male , Ossification, Heterotopic/etiology , Range of Motion, Articular , Retrospective Studies , Total Disc Replacement/adverse effects , Treatment Outcome
3.
J Trace Elem Med Biol ; 37: 37-43, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27473830

ABSTRACT

Zuotai (mainly ß-HgS) and Zhusha (also called as cinnabar, mainly α-HgS) are used in traditional medicines in combination with herbs or even drugs in the treatment of various disorders, while mercury chloride (HgCl2) and methylmercury (MeHg) do not have known medical values but are highly toxic. This study aimed to compare the effects of mercury sulfides with HgCl2 and MeHg on hepatic drug processing gene expression. Mice were orally administrated with Zuotai (ß-HgS, 30mg/kg), α-HgS (HgS, 30mg/kg), HgCl2 (33.6mg/kg), or MeHg (3.1mg/kg) for 7days, and the expression of genes related to phase-1 drug metabolism (P450), phase-2 conjugation, and phase-3 (transporters) genes were examined. The mercurials at the dose and duration used in the study did not have significant effects on the expression of cytochrome P450 1-4 family genes and the corresponding nuclear receptors, except for a slight increase in PPARα and Cyp4a10 by HgCl2. The expressions of UDP-glucuronosyltransferase and sulfotransferase were increased by HgCl2 and MeHg, but not by Zuotai and HgS. HgCl2 decreased the expression of organic anion transporter (Oatp1a1), but increased Oatp1a4. Both HgCl2 and MeHg increased the expression of multidrug resistance-associated protein genes (Mrp1, Mrp2, Mrp3, and Mrp4). Zuotai and HgS had little effects on these transporter genes. In conclusion, Zuotai and HgS are different from HgCl2 and MeHg in hepatic drug processing gene expression; suggesting that chemical forms of mercury not only affect their disposition and toxicity, but also affect their effects on the expression of hepatic drug processing genes.


Subject(s)
Cytochrome P-450 Enzyme System/genetics , Gene Expression Regulation/drug effects , Liver/drug effects , Mercuric Chloride/pharmacology , Mercury/pharmacology , Methylmercury Compounds/pharmacology , Organic Anion Transporters/genetics , Sulfides/pharmacology , Animals , Cytochrome P-450 Enzyme System/biosynthesis , Cytochrome P-450 Enzyme System/metabolism , Gene Expression Regulation/genetics , Liver/enzymology , Liver/metabolism , Male , Mercuric Chloride/administration & dosage , Mercury/administration & dosage , Methylmercury Compounds/administration & dosage , Mice , Mice, Inbred Strains , Organic Anion Transporters/biosynthesis , Organic Anion Transporters/metabolism , Sulfides/administration & dosage
4.
Genet Mol Res ; 14(1): 671-9, 2015 Jan 30.
Article in English | MEDLINE | ID: mdl-25730004

ABSTRACT

The aim of this study was to investigate the effects of the vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR)/K-ras signaling pathways on miRNA21 levels in hepatocellular carcinoma tissues in rats. Eighteen male Sprague-Dawley rats were randomly divided into normal control, model, and VEGF blocking agent groups (N = 6/group). The expression of VEGF mRNA, K-ras protein, and miRNA21 increased significantly (P < 0.05) in the model group compared with the normal control group, and decreased dramatically in the VEGF blocking agent group compared to the model group. The expression of VEGFR mRNA in the model group was higher than that of the control group, and the expression of VEGFR mRNA in the VEGF blocking agent group was significantly higher than that of the control group (P < 0.05). Statistically, there was no difference between the expression of VEGFR mRNA for the VEGF blocking agent group and the model group (P > 0.05). Finally, the expression of the miRNA21 gene in the VEGF blocking agent group was higher than in the control group, and there was a significant statistical difference noted; Pearson's correlation analysis demonstrated that the expression of K-ras protein was positively correlated with miRNA21 in the experimental groups (P = 0.001). The above results showed that the VEGF/VEGFR/K-ras signaling pathway might promote the occurrence and development of hepatocellular carcinoma cells through regulating expression of miRNA21, which has potential clinical value for the development of therapies against biological targets and determining prognosis for patients with hepatocellular carcinoma.


Subject(s)
Carcinoma, Hepatocellular/genetics , Liver Neoplasms/genetics , MicroRNAs/biosynthesis , Proto-Oncogene Proteins p21(ras)/biosynthesis , Vascular Endothelial Growth Factor A/biosynthesis , Vascular Endothelial Growth Factor Receptor-2/biosynthesis , Animals , Carcinoma, Hepatocellular/chemically induced , Carcinoma, Hepatocellular/pathology , Diethylnitrosamine/toxicity , Disease Models, Animal , Gene Expression Regulation, Neoplastic , Humans , Liver Neoplasms/chemically induced , Liver Neoplasms/pathology , MicroRNAs/genetics , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/pathology , Proto-Oncogene Proteins p21(ras)/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Signal Transduction/drug effects , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor Receptor-1/genetics , Vascular Endothelial Growth Factor Receptor-2/genetics
5.
Cell Death Dis ; 5: e1308, 2014 Jun 26.
Article in English | MEDLINE | ID: mdl-24967970

ABSTRACT

Chronic psychological stress has been demonstrated to play an important role in several severe diseases, but whether it affects disease therapy or not remains unclear. Mesenchymal stem cells (MSCs) have been demonstrated to have therapeutic potentials in treating tissue injury based on their multidifferentiation potential toward various cell types. We investigated the effect of chronic restraint stress on therapeutic potential of MSCs on carbon tetrachloride (CCl4)-induced liver injury in mice. CCl4-induced mice were injected with enhanced green fluorescent protein-MSCs, which was followed by chronic restraint stress administration. Corticosterone and RU486, a glucocorticoid receptor (GR) antagonist, were employed in vivo and in vitro, too. In the present study, we illustrated that MSCs could repair liver injury by differentiating into myofibroblasts (MFs) which contribute to fibrosis, whereas stress repressed differentiation of MSCs into MFs displayed by reducing α-smooth muscle actin (α-SMA, a solid marker of MFs) expression. Whereas RU486 could maintain the liver injury reduction and liver fibrosis increases induced by MSCs in stressed mice and block the decrease of α-SMA expression induced by stress. Furthermore, chronic stress inhibited MFs differentiation from MSCs by inhibiting transforming growth factor-ß1 (TGF-ß1)/Smads signaling pathway which is essential for MFs differentiation. Chronic stress reduced autocrine TGF-ß1 of MSCs, but not blunted activation of Smads. All these data suggested that corticosterone triggered by chronic stress impaired liver injury repair by MSCs through inhibiting TGF-ß1 expression which results in reduced MFs differentiation of MSCs.


Subject(s)
Carbon Tetrachloride Poisoning/therapy , Chemical and Drug Induced Liver Injury/therapy , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/metabolism , Stress, Physiological , Transforming Growth Factor beta1/biosynthesis , Allografts , Animals , Anti-Inflammatory Agents/pharmacology , Carbon Tetrachloride Poisoning/genetics , Carbon Tetrachloride Poisoning/metabolism , Carbon Tetrachloride Poisoning/pathology , Cell Differentiation/drug effects , Cell Differentiation/genetics , Chemical and Drug Induced Liver Injury/genetics , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Chronic Disease , Corticosterone/metabolism , Corticosterone/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Hormone Antagonists/pharmacology , Liver Cirrhosis/genetics , Liver Cirrhosis/metabolism , Liver Cirrhosis/pathology , Liver Cirrhosis/therapy , Male , Mesenchymal Stem Cells/pathology , Mice , Mice, Transgenic , Mifepristone/pharmacology , Restraint, Physical , Signal Transduction/drug effects , Signal Transduction/genetics , Smad Proteins/genetics , Smad Proteins/metabolism , Transforming Growth Factor beta1/genetics
6.
Genet Mol Res ; 13(1): 938-44, 2014 Feb 19.
Article in English | MEDLINE | ID: mdl-24634114

ABSTRACT

To investigate the effect of the HMG-CoA reductase inhibitor lovastatin on the expression of the receptor for hepatic low-density lipoprotein (LDL) in a rat model with kidney disease, and to identify the mechanisms in statin treatment of nephrotic syndrome with hyperlipidemia, a rat model with nephrotic syndrome was established. Thirty male Sprague-Dawley rats were treated with lovastatin for 2 weeks using gavage. The expression of protein and mRNA of the LDL receptor in the rat liver was detected with Western blot and RT-PCR, respectively, and blood-biochemical indices were also recorded for each group. Compared with the untreated control group, lovastatin treatment significantly decreased the levels of serum total cholesterol, LDL cholesterol, triglycerides, and urinary protein. In addition, lovastatin treatment significantly increased the levels of serum albumin and hepatic LDL receptor proteins, but had no effect on the expression of hepatic LDL receptor mRNA. Treatment with lovastatin markedly increased the expression of the hepatic LDL receptor in rats with nephrotic syndrome, which was accompanied by significantly improved hyperlipidemia.


Subject(s)
Anticholesteremic Agents/administration & dosage , Hyperlipidemias/drug therapy , Lovastatin/administration & dosage , Nephrotic Syndrome/drug therapy , Receptors, LDL/genetics , Receptors, LDL/metabolism , Animals , Anticholesteremic Agents/therapeutic use , Cholesterol, LDL/blood , Disease Models, Animal , Hyperlipidemias/complications , Liver/drug effects , Liver/metabolism , Liver/pathology , Lovastatin/therapeutic use , Male , Nephrotic Syndrome/pathology , Rats , Rats, Sprague-Dawley , Triglycerides/blood
7.
Cell Death Dis ; 4: e844, 2013 Oct 10.
Article in English | MEDLINE | ID: mdl-24113178

ABSTRACT

Stem cells were characterized by their stemness: self-renewal and pluripotency. Mesenchymal stem cells (MSCs) are a unique type of adult stem cells that have been proven to be involved in tissue repair, immunoloregulation and tumorigenesis. Irradiation is a well-known factor that leads to functional obstacle in stem cells. However, the mechanism of stemness maintenance in human MSCs exposed to irradiation remains unknown. We demonstrated that irradiation could induce reactive oxygen species (ROS) accumulation that resulted in DNA damage and stemness injury in MSCs. Autophagy induced by starvation or rapamycin can reduce ROS accumulation-associated DNA damage and maintain stemness in MSCs. Further, inhibition of autophagy leads to augment of ROS accumulation and DNA damage, which results in the loss of stemness in MSCs. Our results indicate that autophagy may have an important role in protecting stemness of MSCs from irradiation injury.


Subject(s)
Autophagy/radiation effects , Mesenchymal Stem Cells/pathology , Mesenchymal Stem Cells/radiation effects , Radiation, Ionizing , Reactive Oxygen Species/metabolism , Adult , Autophagy/drug effects , DNA Damage , Humans , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/ultrastructure , Protective Agents/pharmacology , Sirolimus/pharmacology , Vacuoles/drug effects , Vacuoles/metabolism , Vacuoles/radiation effects , Vacuoles/ultrastructure
8.
Cell Death Dis ; 4: e501, 2013 Feb 21.
Article in English | MEDLINE | ID: mdl-23429287

ABSTRACT

Many reports have shown that autophagy has a role as both a promoter and inhibitor in tumor development. However, the mechanism of this paradox is unknown. Tumor development is a multistep process. Therefore, we investigated whether the role of autophagy in hepatocarcinoma formation depended on the stage of tumor development. Based on our results, autophagy inhibition by chloroquine had a tumor-promotive effect in the rat model with N-diethylnitrosamine-induced hepatocarcinogenesis in its dysplastic stage (Ds) and a tumor-suppressive effect in its tumor-forming stage (Ts). In the Ds, autophagy inhibition enhanced cell proliferation, DNA damage and inflammatory cytokines expression in liver. These changes were dependent on the upregulation of reactive oxygen species (ROS) that was resulted from autophagy inhibition, and ultimately accelerated the process of hepatocarcinogenesis. However, in the Ts, autophagy inhibition restrained tumor formation by decreasing tumor cell survival and proliferation. In this stage, autophagy inhibition led to excessive ROS accumulation in the tumor, which promoted cell apoptosis, and prominently suppressed tumor cell metabolism. Taken together, our data suggested that autophagy suppressed hepatocarcinogenesis in the Ds by protecting normal cell stability and promoted hepatocarcinogenesis in the Ts by supporting tumor cells growth. Autophagy always had a role as a protector throughout the process of hepatocarcinoma development.


Subject(s)
Autophagy/drug effects , Carcinoma, Hepatocellular/chemically induced , Chloroquine/pharmacology , Liver Neoplasms/chemically induced , Protective Agents/pharmacology , Animals , Antioxidants/pharmacology , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/prevention & control , Cell Proliferation/drug effects , Cell Transformation, Neoplastic/drug effects , Cytokines/metabolism , DNA Damage , Diethylnitrosamine/toxicity , Liver/metabolism , Liver Neoplasms/mortality , Liver Neoplasms/prevention & control , Male , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Survival Rate , Up-Regulation
9.
Acta Anaesthesiol Scand ; 56(5): 565-70, 2012 May.
Article in English | MEDLINE | ID: mdl-22489991

ABSTRACT

BACKGROUND: Because the Bonfils fibrescope has a semi-rigid optical stylet and is similar in shape to a lightwand, we aimed to evaluate and compare the efficacy of transillumination-assisted orotracheal intubation with the Bonfils fibrescope and the Trachlight(TM) lightwand in patients with normal airways. METHODS: As a preliminary investigation to form a basis for later studies, therefore, we performed a randomized, single-blind study of 300 patients with normal airways to compare the efficiency of Trachlight and transillumination-assisted Bonfils orotracheal intubation in these patients. In both groups, orotracheal intubation was performed using a transillumination technique. The first attempt and overall success rates of tracheal intubation, the times required, and any untoward effects were recorded. RESULTS: Although the overall success rates were similar for Bonfils and Trachlight intubations (97.3% and 98.7%, respectively), tracheal intubation was successful on the first attempt in 87.3% of patients with the Bonfils fibrescope compared with 95.3% of patients with the Trachlight (P < 0.05). The mean intubation time for the first attempt was 15 ± 5 s with the Bonfils fibrescope and 9 ± 2 s with the Trachlight (P < 0.001). Patients intubated using the Bonfils fibrescope also experienced significantly more sore throat and hoarseness than those intubated using the Trachlight. CONCLUSIONS: For patients with normal airways, the Trachlight is superior for orotracheal intubation with respect to reliability, rapidity, and safety compared with the Bonfils fibrescope used with the transillumination technique.


Subject(s)
Intubation, Intratracheal/methods , Laryngoscopes , Transillumination , Adult , Anesthesia, General , Anesthetics, Inhalation , Female , Fiber Optic Technology , Hoarseness/epidemiology , Humans , Intubation, Intratracheal/adverse effects , Male , Monitoring, Intraoperative , Mouth/anatomy & histology , Nitrous Oxide , Pharyngitis/epidemiology , Postoperative Complications/epidemiology , Surgery, Plastic , Treatment Outcome
10.
Eur J Surg Oncol ; 37(6): 513-20, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21324414

ABSTRACT

AIMS: Ras/Raf/mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling cascades play important roles in the transmission of signals involved in apoptosis. Importantly, components of these pathways are aberrantly expressed in human cancer. However, there is limited data linking clinical outcomes with the aberrant expression of this pathway. The present study analyzed the prognostic values of pan-Ras, Raf-1, phosphorylated MEK1 (pMEK1) and phosphorylated ERK1/2 (pERK1/2) in hepatocellular carcinoma (HCC). METHODS: Expression of pan-Ras, Raf-1, pMEK1 and pERK1/2 in 81 HCC patients who underwent curative resection was examined by immunohistochemical staining. Long-term survival after resection of patients according to the expression of pan-Ras, Raf-1, pMEK1 and pERK1/2 was assessed using univariate analysis and multiple Cox proportional hazards model. RESULTS: In univariate analysis, patients with Raf-1 or pMEK1 overexpression had shorter disease-free survival (DFS) (P<0.05) and poorer overall survival (OS) (P<0.05) than groups with weak-expression of Raf-1 or pMEK1, respectively. Patients with pan-Ras overexpression had poorer overall survival (OS) (P<0.05) than the group with weak-expression of pan-Ras. Importantly, Raf-1 overexpression was a promising prognostic marker for poor survival according to multivariate Cox regression analysis (DFS, Hazard Ratio 1.807, P = 0.035; OS, Hazard Ratio 1.959, P = 0.044). CONCLUSIONS: Raf-1 overexpression could be considered as an independent prognostic biomarker in HCC and may predict early tumor recurrence and death for HCC patients. It can be used to stratify patients at higher risk for poor prognosis and help to select the appropriate therapeutic regime of HCC.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Hepatocellular/metabolism , Liver Neoplasms/metabolism , MAP Kinase Kinase 1/metabolism , Mitogen-Activated Protein Kinase 1/metabolism , Signal Transduction , raf Kinases/metabolism , ras Proteins/metabolism , Adult , Aged , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/surgery , Disease-Free Survival , Female , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Liver Neoplasms/mortality , Liver Neoplasms/pathology , Liver Neoplasms/surgery , Male , Middle Aged , Neoplasm Recurrence, Local/diagnosis , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Risk Factors
11.
Genet Mol Res ; 9(4): 2199-206, 2010 Nov 09.
Article in English | MEDLINE | ID: mdl-21064027

ABSTRACT

Milk composition and body measurement traits, influenced by genes and environmental factors, play important roles in value assessments of efficiency and productivity in dairy goats. Lactoferrin (LF), involved in the efficient expression of protein in milk, is also an anabolic factor in skeletal tissue and a potent osteoblast survival factor. Therefore, it is an important candidate gene for milk composition and body measurement trait selection in marker-assisted selection. We employed PCR-SSCP and DNA sequencing to screen the genetic variations of the LF gene in 549 Chinese dairy goats. A novel single-nucleotide polymorphism (SNP) (G198A in exon II) of the LF gene was detected. The frequencies of the AA genotype were 0.0285 and 0.0261 in GZ and SN populations, respectively. Both populations were found to have low levels of polymorphism and were in Hardy-Weinberg disequilibrium (P < 0.05). We found significant (P < 0.05) associations of the SNP marker with milk protein and acidity in the total population; animals with the AA genotype had higher mean values for milk protein than those with the GA genotype. Animals with genotype AA had higher mean values for withers height than those with genotype GG (P < 0.05). We concluded that this SNP of the LF gene has potential as a genetic marker for milk composition and body traits in dairy goat breeding.


Subject(s)
Dairying , Goats/anatomy & histology , Lactoferrin/genetics , Milk/chemistry , Polymorphism, Single Nucleotide , Animals , Base Sequence , DNA Primers , Heterozygote , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational
12.
Phytomedicine ; 16(2-3): 138-45, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19135347

ABSTRACT

It has been reported that oxidatively modified low-density lipoprotein (Ox-LDL) involvement with vascular endothelial growth factor (VEGF) and foam cell formation play an important role in atherosclerosis (AS). Protective effects of Ginkgo biloba extract (EGb 761) have been identified for some cardiovascular and neurological disorders. The aim of this study was to investigate whether Ox-LDL regulates VEGF expression in human THP-1 monocytes, as well as the effect of EGb 761 on VEGF expression and the formation of foam cells. After exposure to Ox-LDL alone or in combination with EGb 761 for up to 48h, cell viability was measured using the MTT assay. VEGF protein content in the supernatant was analyzed by enzyme-linked immunosorbent assay (ELISA). VEGF mRNA was determined by real-time PCR. To determine the effect of EGb 761 on foam cell formation, an Ox-LDL-induced foam cell model was used. Ox-LDL inhibited the growth of THP-1 cells and EGb 761 increased the cell survival rate. Ox-LDL markedly increased VEGF expression in THP-1 cells in a time- and concentration-dependent manner, which was significantly suppressed by EGb 761. EGb 761 also inhibited monocyte/macrophage-derived foam cell formation. These results suggest that Ox-LDL is involved in the development of human AS through VEGF induction in monocytes, and that EGb 761 prevents in vitro atherogenesis, probably via downregulation of VEGF expression in monocytes and inhibition of monocyte/macrophage-derived foam cell formation. The findings suggest a mechanism for the in vivo anti-AS effect of EGb 761 and support its potential clinical use in AS.


Subject(s)
Antioxidants/pharmacology , Foam Cells/drug effects , Ginkgo biloba , Lipoproteins, LDL/metabolism , Monocytes/drug effects , Plant Extracts/pharmacology , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Atherosclerosis/prevention & control , Cell Survival/drug effects , Down-Regulation , Enzyme-Linked Immunosorbent Assay , Foam Cells/metabolism , Humans , Monocytes/metabolism , Phytotherapy , Plant Leaves , RNA, Messenger/metabolism , Vascular Endothelial Growth Factor A/metabolism
13.
J Chem Phys ; 124(7): 74302, 2006 Feb 21.
Article in English | MEDLINE | ID: mdl-16497031

ABSTRACT

We have developed an effusive laser photodissociation radical source, aiming for the production of vibrationally relaxed radicals. Employing this radical source, we have measured the vacuum ultraviolet (VUV) photoionization efficiency (PIE) spectrum of the propargyl radical (C(3)H(3)) formed by the 193 nm excimer laser photodissociation of propargyl chloride in the energy range of 8.5-9.9 eV using high-resolution (energy bandwidth = 1 meV) multibunch synchrotron radiation. The VUV-PIE spectrum of C(3)H(3) thus obtained is found to exhibit pronounced autoionization features, which are tentatively assigned as members of two vibrational progressions of C(3)H(3) in excited autoionizing Rydberg states. The ionization energy (IE = 8.674 +/- 0.001 eV) of C(3)H(3) determined by a small steplike feature resolved at the photoionization onset of the VUV-PIE spectrum is in excellent agreement with the IE value reported in a previous pulsed field ionization-photoelectron study. We have also calculated the Franck-Condon factors (FCFs) for the photoionization transitions C(3)H(3) (+)(X;nu(i),i = 1-12)<--C(3)H(3)(X). The comparison between the pattern of FCFs and the autoionization peaks resolved in the VUV-PIE spectrum of C(3)H(3) points to the conclusion that the resonance-enhanced autoionization mechanism is most likely responsible for the observation of pronounced autoionization features. We also present here the VUV-PIE spectra for the mass 39 ions observed in the VUV synchrotron-based photoionization mass spectrometric sampling of several premixed flames. The excellent agreement of the IE value and the pattern of autoionizing features of the VUV-PIE spectra observed in the photodissociation and flames studies has provided an unambiguous identification of the propargyl radical as an important intermediate in the premixed combustion flames. The discrepancy found between the PIE spectra obtained in flames and photodissociation at energies above the IE(C(3)H(3)) suggests that the PIE spectra obtained in flames might have contributions from the photoionization of vibrationally excited C(3)H(3) and/or the dissociative photoionization processes involving larger hydrocarbon species formed in flames.

14.
Surg Endosc ; 20(2): 281-5, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16362478

ABSTRACT

BACKGROUND: Radiofrequency ablation (RFA), currently used extensively for liver tumors, also has been applied successfully to hepatic cavernous hemangioma (HCH) percutaneously. The aim of this study was to assess the feasibility, safety, and efficacy of laparoscopic RFA for patients with HCHs. METHODS: Between March 2001 and March 2004, 27 patients with symptomatic and rapid-growth lesions were treated by laparoscopic RFA using the RF-2000 generator system. The treatment-related complications were observed. All the patients were followed up with helical computed tomography scans and ultrasonography at regular intervals to assess the therapeutic efficacy of laparoscopic RFA. RESULTS: This study assessed 9 men and 18 women with a mean age of 41.6 +/- 8.3 years. Three additional intrahepatic lesions missed preoperatively were found in three patients on intraoperative ultrasound. A total of 27 patients with 50 liver lesions were treated successfully with laparoscopic RFA. The mean maximum tumor diameter was 5.5 +/- 2.0 cm. The mean length of time for RFA per lesion was 20.7 +/- 11.9 min, and the mean blood loss was 134.4 +/- 88.9 ml. Laparoscopic cholecystectomy was performed simultaneously for gallstones in 13 patients and for abutting of gallbladder from hemangioma in 2 patients. In addition, 3 patients also had a laparoscopic deroofing of simple hepatic cysts. Although postoperative low-grade fever and transient elevation of serum transaminase levels were observed in 13 patients, there were no complications related to laparoscopic RFA. During a median follow-up period of 21 months (range, 12-42 months), complete lesion necrosis was achieved for all the patients. CONCLUSIONS: Laparoscopic RFA therapy is a safe, feasible, and effective treatment option for patients with symptomatic and rapid-growth HCHs located on the surface of the liver or adjacent to the gallbladder. Intraoperative ultrasonography is a useful adjunct for detecting additional liver lesions and offering more accurate targeting for RFA.


Subject(s)
Catheter Ablation , Hemangioma, Cavernous/surgery , Laparoscopy , Liver Neoplasms/surgery , Minimally Invasive Surgical Procedures , Adult , Catheter Ablation/adverse effects , Feasibility Studies , Female , Follow-Up Studies , Humans , Laparoscopy/adverse effects , Liver/diagnostic imaging , Male , Middle Aged , Tomography, Spiral Computed , Treatment Outcome , Ultrasonography
15.
Mol Pathol ; 56(6): 362-7, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645700

ABSTRACT

AIMS: To explore the role of Fas in cardiomyocytic apoptosis induced by ischaemia through determining the histological relation between Fas expression and apoptosis in rat myocardium during ischaemia/infarction. METHODS: The myocardial ischaemia model was produced by ligating the left coronary artery in Sprague-Dawley rats. The rats were killed from 10 minutes to seven days after surgery. Apoptotic myocardial cells were detected by the in situ terminal deoxynucleotidyl transferase mediated nick end labelling method, and the expression of Fas by immunohistochemistry and western blotting. RESULTS: Cardiomyocytic apoptosis appeared from three to 36 hours after ischaemia. The expression of Fas could be detected by western blot from before surgery to seven days of ischaemia. Apoptosis and the expression of Fas in the cardiomyocytes appeared in different regions of the myocardium: apoptosis in the ischaemic region, Fas in the regions surrounding ischaemic myocardium. CONCLUSION: These results suggest that there is a tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion. Fas might not directly regulate the apoptosis of cardiomyocytes induced by ischaemia.


Subject(s)
Apoptosis , Myocardial Ischemia/pathology , Myocardium/pathology , fas Receptor/analysis , Animals , Biomarkers/analysis , Blotting, Western/methods , Immunohistochemistry/methods , In Situ Nick-End Labeling , Male , Models, Animal , Myocardial Ischemia/immunology , Myocardium/immunology , Rats , Rats, Sprague-Dawley , Time Factors
16.
Cell Death Differ ; 10(2): 193-202, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12700647

ABSTRACT

Activation-induced cell death (AICD), a process mediated by CD95 and CD95 ligand (CD95L), plays a critical role in regulating homeostasis of the immune system. Although the role of sphingolipids such as ceramides has been suggested to participate in CD95-mediated apoptosis, the exact role of these molecules in this process remains controversial. We employed myriocin, a specific inhibitor of serine palmitoyl-CoA transferase that mediates the first commitment step in sphingolipid synthesis. We found that myriocin could effectively block AICD in T-cell hybridomas and T-cell blasts. However, fumonisin B1, an inhibitor of the final step of ceramide synthesis, or inhibitors of sphingomyelinases did not prevent AICD. Furthermore, ceramide analogues, such as C2 and C6, could not reverse the inhibitory effect of myriocin. Interestingly, sphinganine, an intermediate of ceramide synthesis, completely reversed the inhibitory effect of myriocin, indicating a critical role of sphinganine. Myriocin did not modulate the expression of CD95 or CD95L, instead, it interfered with the early steps of CD95-mediated caspase activation. Therefore, we have uncovered a novel mechanism by which sphingolipid intermediates regulate CD95-mediated apoptosis.


Subject(s)
Apoptosis/drug effects , Lymphocyte Activation/drug effects , Sphingolipids/metabolism , Sphingosine/analogs & derivatives , Sphingosine/pharmacology , T-Lymphocytes/drug effects , Animals , Caspase Inhibitors , Caspases/drug effects , Cells, Cultured , Enzyme Activation/drug effects , Fas Ligand Protein , Fatty Acids, Monounsaturated/pharmacology , Female , Hybridomas/drug effects , Hybridomas/immunology , Immunosuppressive Agents/pharmacology , Membrane Glycoproteins/physiology , Mice , Mice, Inbred BALB C , Protein Kinase C/antagonists & inhibitors , Spleen/cytology , T-Lymphocytes/immunology , fas Receptor/physiology
17.
Leukemia ; 16(9): 1673-9, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12200680

ABSTRACT

Therapy-related myelodysplastic syndrome and acute myelogenous leukemia (t-MDS/AML) are serious complications of chemotherapy and radiotherapy for cancer. High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) may be associated with an increased incidence of these complications. The frequency of t-MDS/AML after ASCT for breast cancer is uncertain. We reviewed our database of 379 consecutive breast cancer ASCT patients treated with alkylator-based chemotherapy, followed for a median of 1.52 years (range 0-8.97), with a median survival of 6.16 years. Three patients have developed tMDS/AML. The probability of developing this complication at 5 years is 0.032 in our series. We have used pathologic, cytogenetic and molecular methods to evaluate which portions of therapy may have predisposed to the development of this complication. Cytogenetic abnormalities were not found in the stem cell harvests of these patients by metaphase analysis or by fluorescence in situ hybridization (FISH). One patient demonstrated a clonal X chromosome inactivation pattern in her stem cell harvest, indicating pre-transplant chemotherapy may have been responsible for the development of her leukemia. As two of our patients developed this complication at greater than 4 years post-transplant, the number of cases may increase with longer follow-up. While the incidence appears to be low, further prospective and retrospective analysis will be necessary to determine which portions of therapy predispose to the development of t-MDS/AML in patients undergoing ASCT for treatment of breast cancer.


Subject(s)
Breast Neoplasms/therapy , Carcinoma, Ductal, Breast/therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Leukemia, Myeloid/etiology , Myelodysplastic Syndromes/etiology , Neoplasms, Second Primary/etiology , Acute Disease , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chromosome Aberrations , Cyclophosphamide/therapeutic use , DNA, Neoplasm/metabolism , Doxorubicin/therapeutic use , Female , Fluorouracil/therapeutic use , Humans , In Situ Hybridization, Fluorescence , Karyotyping , Middle Aged , Neoplasms, Second Primary/pathology , Predictive Value of Tests , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Retrospective Studies , Survival Rate , Time Factors , Transplantation Conditioning/adverse effects , Transplantation, Autologous
18.
Respir Med ; 95(5): 379-86, 2001 May.
Article in English | MEDLINE | ID: mdl-11392579

ABSTRACT

Few studies have specifically evaluated controller therapy in patients with mild persistent asthma. We used a subgroup analysis to investigate the effects of montelukast, a potent cysteinyl leukotriene receptor antagonist, on adult patients on the milder end of the asthma severity spectrum. We have identified seven double-blind, randomized, placebo-controlled studies of adult patients with mild-to-moderate chronic asthma in which montelukast was investigated. Subsets of patients with baseline forced expiratory volume in 1 sec (FEV1) > 80% and > 75% predicted or further restricted by less than daily rescue beta-agonist use were included as four cohorts (A, B, C, D), and efficacy measures, including change in FEV1 rescue-free days, beta-agonist use, nocturnal awakenings and blood eosinophil counts were evaluated. Cohorts A to D comprised 21%, 8%, 11%, and 4%, respectively, of patients from these studies. Mean pretreatment FEV1 ranged from 81% to 84% predicted and daily beta-agonist use from 2.4 to 4.5 puffs day(-1) in the four cohorts. Pooled results demonstrated a treatment effect for montelukast over placebo in all cohorts, for all endpoints. There was a significant improvement in FEV1 in montelukast-treated patients (7-8% over baseline) compared with placebo (1-4% over baseline, between-group difference P < or = 0.02) for all cohorts. Similarly, the percentage of rescue-free days increased substantially more with montelukast (22-30%) than with placebo (8-13%). This subgroup analysis indicates that montelukast produced improvements in parameters of asthma control in patients with milder persistent asthma that should be confirmed in additional prospective trials.


Subject(s)
Acetates/therapeutic use , Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Quinolines/therapeutic use , Adolescent , Adrenergic beta-Agonists/administration & dosage , Adult , Aged , Analysis of Variance , Asthma/blood , Asthma/complications , Cyclopropanes , Double-Blind Method , Drug Therapy, Combination , Eosinophils , Female , Forced Expiratory Volume/drug effects , Humans , Leukocyte Count , Male , Middle Aged , Randomized Controlled Trials as Topic , Severity of Illness Index , Sulfides , Treatment Outcome
19.
Zhongguo Zhong Yao Za Zhi ; 26(2): 122-3, 2001 Feb.
Article in Chinese | MEDLINE | ID: mdl-12525109

ABSTRACT

OBJECTIVE: A fingerprint of raw material, extracted and injections of radix notoginseng has been studied and provides the quality information. METHOD: Polaris C18-A column was used, with mixtures of acetonitrile and water as mobile phase in a gradient mode. The wavelength of measurement was 203 nm. RESULT: According to the selected chromatographic conditions, a good fingerprint of radix notoginseng and its extract, preparation has been described. CONCLUSION: The method is simple, accurate with good reproducibility. It may be practical value for the quality control of sample for radix notoginseng and its preparation.


Subject(s)
Drugs, Chinese Herbal/chemistry , Ginsenosides/chemistry , Panax/chemistry , Plants, Medicinal/chemistry , Chromatography, High Pressure Liquid , Drugs, Chinese Herbal/isolation & purification , Ginsenosides/isolation & purification , Injections , Plant Roots/chemistry
20.
Zhongguo Zhong Yao Za Zhi ; 26(1): 47-9, 2001 Jan.
Article in Chinese | MEDLINE | ID: mdl-12525121

ABSTRACT

OBJECTIVE: Studying changes of chemical constituents of Cinnamomum cassia after compatibility in Coptis chinensis; determining the amount of cinnamic acid in the decoction. METHOD: An YWG C18 column was used with a mobile phase of CH3CN-0.01% H3PO4(27:73), the flow rate was 1.0 ml.min-1 and the detection wavelength was 280 nm. RESULT AND CONCLUSION: The calibration curve of cinnamic acid had good linear relationship in the range of 0.112-4.48 micrograms. The average recovery was 100.0%, the relative standard deviation was 0.66%. The amount of cinnamic acid was decreased in the decoction, and the decreased degree was related with the ratio of C. chinensis to C. cassia.


Subject(s)
Cinnamates/analysis , Cinnamomum aromaticum/chemistry , Coptis/chemistry , Plants, Medicinal/chemistry , Chromatography, High Pressure Liquid , Drug Combinations
SELECTION OF CITATIONS
SEARCH DETAIL
...